Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.67 |
| ▸ | CASP2 | P42575 | 1/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.55 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.55 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.52 |
| ▸ | RRM1 | P23921 | 1/20 | 0.52 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80555 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL292693 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL3055110 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL19468503 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL2185171 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL19468457 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL76613 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL944633 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL19468513 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL1820932 | 1.00 | EPHX1 (0.67) | EPHX1CASP2ZDHHC20ZDHHC2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-03-14 | — | — | US | claimed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024157871-A1 | FILM-FORMING AUXILIARY AGENT FOR CHEMICAL VAPOR DEPOSITION, COATING SOLUTION FOR CHEMICAL VAPOR DEPOSITION, METAL OXIDE FILM, AND FILM-FORMING METHOD FOR METAL OXIDE FILM | 日油株式会社 | 2024-08-02 | — | — | WO | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240238331-A1 | COATINGS, FORMULATIONS, USES AND COATING METHODS | BIOINTERACTIONS LTD (GB) | 2024-07-18 | — | — | US | disclosed |
| CN-118239864-A | Method for preparing ureido compound and amino compound through alcohol dehydration under urea action and application of ureido compound and amino compound | 华南理工大学 | 2024-06-25 | — | — | CN | disclosed |
| EP-4369935-A1 | COATINGS, FORMULATIONS, USES AND COATING METHODS | Biointeractions Ltd (GB) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024043261-A1 | AZO COMPOUND OR SALT THEREOF, AND POLARIZING FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE COMPRISING SAME | 日本化薬株式会社 | 2024-02-29 | — | — | WO | disclosed |
| CN-114026199-B | Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof | 日本化药株式会社 | 2023-12-26 | — | — | CN | disclosed |
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-03-14 | — | — | US | disclosed |
| US-6165704-A | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| US-4888268-A | DEVELOPING IN PRESENCE OF AMINE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-19 | — | — | US | disclosed |
| US-4871790-A | DISPERSING METAL PARTICLES IN MONOMERS AND POLYMERIZING OR DISSOLVING POLYMER IN LIQUID CONTAINING METAL PARTICLES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-03 | — | — | US | disclosed |
| EP-0318196-A2 | Colloidal metals in monomers or polymers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4448816-A | N-ISOCYANTOALKANOYL SUBSTITUTED CYCLIC UREAS USED IN POLYURETHANE COATINGS | THE UPJOHN COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| US-4217436-A | N,N*-HYDROCARBYLENEDICARBONYLBIS/CYCLIC UREA/ | THE UPJOHN COMPANY (US) | 1980-08-12 | — | — | US | disclosed |
| US-4190599-A | ACRYLATE COPOLYMER AND EPOXY RESIN | THE UPJOHN COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4138398-A | Bis-cyclic ureas | THE UPJOHN COMPANY (US) | 1979-02-06 | — | — | US | disclosed |
| US-3940370-A | Method of making polyureas | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238331-A1 | COATINGS, FORMULATIONS, USES AND COATING METHODS | GNE, PUF60, HPSE | EPHX1 3779/4885CASP2 3027/4885ZDHHC20 3034/4885 |
| US-20020032238-A1 | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments | MTTP, CETP, FABP1 | EPHX1 1716/4885CASP2 2850/4885ZDHHC20 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.